首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
admin
2011-02-03
88
问题
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by breast implants produced by the defunct French company PIP, even as a scientific expert review it ordered concluded there was currently "insufficient evidence" that women using its products faced greater health risks than others.
John Dalli, health and consumer policy commissioner, pledged to examine surveillance and operation of the "notified bodies" that scrutinise medical devices across the EU in a current review of legislation, stressing: "The capacity to detect and minimise the risk of fraud must be increased."
His comments followed an official report released on Wednesday in France that called for national and EU-wide co-operation including random inspections and sampling of medical devices to prevent a repeat of the fraudulent use of substandard non-medical-grade silicone by PIP in implants sold to up to 400,000 women around the world.
Xavier Bertrand, France’s minister of health, called for enhanced action in France and across Europe in the wake of the study, which highlighted that Afssaps, the French medical regulator, did not inspect PIP from 2001 until a tip-off led officials to inspect and close down the company in 2010. Jean-Claude Mas, its founder, is under police investigation for manslaughter.
Mr. Bertrand has pledged to hire more health inspectors and undertake random checks on medical device companies following growing concerns over its regulatory system highlighted by the widespread use of PIP’s substandard breast implants.
A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK, Germany and the Czech Republic and has helped spark a fresh debate over tougher EU regulation of medical devices, which are subject to far less scrutiny than pharmaceuticals.
However, a review released on Thursday by the EU’s own Scientific Committee on Emerging and Newly Identified Health Risks concluded: "Breast implants can fail, regardless of manufacturer, and the probability of failure increases with time since implantation. In most cases, breast implant failure appears to be without identifiable health consequences for the patient with the exception of possible local complications."
It stressed that limited data meant that while there was no link between breast implants and cancer, there was a need for further work to understand the specific risks from the PIP products.
Mr. Bertrand has endorsed calls for a parliamentary inquiry in France as well as a report from the country’s social affairs inspectorate, mirroring similar moves that led to tough new requirements for the pharmaceutical industry introduced last year in the wake of concerns about Servier’s drug Mediator.
Medical device manufacturers have called for reforms to ensure that the national "notified bodies" which audit the quality of their products across Europe are of a consistently high standard, while cautioning that tough new regulatory requirements could harm the EU’s competitive advantage.
The French study showed that Afssaps had received multiple warnings over the relatively high failure rate of PIP implants compared with those made by other companies, even though the overall proportion remained modest.
From Financial Times, February 2, 2012
Which of the following statements is INCORRECT according to the passage?
选项
A、Women using the breast implants faced greater health risks.
B、The capacity to detect the risk of fraud should be increased.
C、An official report called for cooperation in France and in other parts of EU.
D、France’s minister of health has pledged to hire more health inspectors.
答案
A
解析
本题为概括题。根据第一段“there was currently‘insufficient evidence’that women using its products faced greater health risks than others”可知A错误;根据第二段“The capacity to detect and minimise the risk of fraud must be increased”可知B正确;根据第三段“…an official report…that called for national and EU wide co-operation…”可知C正确;根据第五段“Mr.Bertrand has pledged to hire more health inspectors and…”可知D正确。
转载请注明原文地址:https://kaotiyun.com/show/vM1K777K
0
专业英语四级
相关试题推荐
Thethoughtofgoingbackhomewas______kepthimhappywhilehewasworkingabroad.
______teamwinsthematchonSaturdaynightwillgothroughtothenationalchampionships.
Thegreatestrecentsocialchangeshavebeen【C1】______thelivesofwomen.Duringthe20thcenturytherehasbeenaremarkable
Thegreatestrecentsocialchangeshavebeen【C1】______thelivesofwomen.Duringthe20thcenturytherehasbeenaremarkable
Researchershaveestablishedthatwhenpeoplearementallyengaged,biochemicalchangesoccurinthebrainthatallowittoact
TheEnglishlanguageexistsinaconditionofeverlastingdanger,itsAmericanbranchmostparticularly,assaultedasitisfrom
Thatexperiencesinfluencesubsequentbehaviorisevidenceofanobviousbutneverthelessremarkableactivitycalledremembering
ThecolonistsofPlymouth,Massachusetts,whohadsettledtherehadleftEnglandbecausetheyfelt______ofreligiousfreedom.
Whatistheconcernofordinarypeopleaboutthe"GreenhouseEffect"?
TheNationalTrustinBritain,togetherwithsimilarvoluntaryorganizations,playsanincreasinglyimportantpartinthepreser
随机试题
以下常用的高级程序设汁语言中,用来开发UNIX核的是______。
赵某,男,49岁,眩晕,耳鸣,头目胀痛月余,素有血压高,伴口苦心烦,失眠多梦,遇情志不遂而加重,心悸易怒,BPl60/100mmHg,头颅CT示:腔隙性脑梗塞,舌红苔黄,脉弦数
生物药剂学的概念是
2015年3月13日公告,经现场检查和审核批准,佛慈制药公司符合国家《药品生产质量管理规范》的要求,近日收到甘肃省食品药品监督管理局颁发的GMP证书。证书编号:GS20150140,认证范围:片剂、硬胶囊剂、丸剂(浓缩丸,浓缩水丸、水丸、浓缩水蜜丸)。
对药物吸收有明显影响的因素主要有()。
根据《房屋建筑与装修工程工程量清单计算规范》,工程计量时,若以“个”、“件”为单位,汇总的有效位数应取()。
为保证安全疏散,电影院观众厅疏散走道的净宽度,应按每百人不少于()m的净宽度计算。
下列各项中,应计入投资收益的有()。
以下4种编码方式中,属于差分曼彻斯特编码的是(1)。
A、8,500.B、160.C、1,000.D、500.B题目问有多少学校的行政办公室被学生关闭。新问中提到,自周三以来,学生关闭了月收费超过1000卢比的160所学校的行政办公室。故B项正确。
最新回复
(
0
)